The CACNA1F gene plays a critical role in the proper functioning of the retina, the light-sensitive tissue at the back of the eye. Mutations in this gene are associated with Aland Island Eye Disease (AIED), a rare X-linked genetic disorder that affects males more severely than females. AIED is characterized by a range of visual impairments, including reduced visual acuity, nystagmus (involuntary eye movement), and abnormalities in color vision.
To diagnose this condition, DNA Labs UAE offers a genetic test specifically targeting the CACNA1F gene. This test is crucial for identifying mutations in the CACNA1F gene that are responsible for Aland Island Eye Disease. By analyzing a small sample of the patient's DNA, the test can confirm the presence of the genetic mutation associated with AIED, thus providing a definitive diagnosis.
The cost of the CACNA1F gene test at DNA Labs UAE is 4400 AED. This comprehensive testing service not only aids in the diagnosis of Aland Island Eye Disease but also plays a pivotal role in guiding the management and treatment of affected individuals. Additionally, it can be instrumental in genetic counseling for families affected by this condition, helping them understand the risks of transmission to future generations.
The GPR143 gene, associated with Ocular Albinism Type I, also known as Nettleship-Falls Type Albinism, plays a crucial role in determining the pigmentation of the eyes, skin, and hair. Mutations in this gene can lead to a reduction in melanin production, which is characteristic of this condition, leading to visual problems and light sensitivity. The genetic test for this specific type of albinism focuses on identifying mutations within the GPR143 gene to confirm a diagnosis, guide treatment, and inform family planning decisions.
At DNA Labs UAE, a specialized test is available for those suspected of having Ocular Albinism Type I (Nettleship-Falls Type). This test is meticulously designed to detect the presence of mutations in the GPR143 gene, offering a critical tool for accurate diagnosis and management of the condition. The cost of the test is 4400 AED, reflecting the comprehensive nature of the analysis and the advanced technology utilized to ensure precise results. This test is an invaluable resource for affected individuals and their families seeking clarity on their genetic status and looking to understand the implications for their health and vision.
The SLC24A5 gene plays a critical role in the pigmentation of the skin, hair, and eyes, and mutations in this gene can lead to a form of albinism known as oculocutaneous albinism type 6 (OCA6). OCA6 is a nonsyndromic genetic condition, meaning it primarily affects pigmentation and does not significantly impact other bodily systems. Individuals with OCA6 typically present with lighter skin and hair color compared to non-affected family members, and may also experience vision problems, which are common in albinism due to the lack of melanin in the eyes.
Recognizing the importance of accurate diagnosis and understanding of this condition, DNA Labs UAE offers a genetic test specifically targeting the SLC24A5 gene to identify mutations associated with OCA6. The test is a crucial tool for families seeking to understand their genetic makeup, particularly for those with a history of albinism, as it can provide definitive confirmation of the condition and guide future family planning decisions.
The cost of the SLC24A5 gene albinism oculocutaneous nonsyndromic genetic test at DNA Labs UAE is 4400 AED. This test is conducted with state-of-the-art technology to ensure high accuracy and reliability of results. Upon completion, individuals receive a comprehensive report that not only details the presence of any mutations in the SLC24A5 gene but also offers insights into the implications of these genetic findings. This information can be invaluable for affected individuals and their families, offering them a clearer understanding of the condition and how to manage it moving forward.
The TYR Gene Albinism Oculocutaneous Type 1B Genetic Test is a specialized diagnostic tool offered by DNA Labs UAE, aimed at identifying mutations in the TYR gene which are responsible for Oculocutaneous Albinism Type 1B (OCA1B). OCA1B is a form of albinism characterized by reduced melanin production, leading to lighter skin, hair, and eye color than non-affected family members, and may include vision abnormalities. The test is crucial for early diagnosis and management of the condition, helping in understanding the risk of passing the genetic mutation to future generations. Priced at 4400 AED, this test is a valuable resource for individuals with a family history of albinism or those seeking genetic counseling. Conducted in the advanced facilities of DNA Labs UAE, the test offers accurate, reliable results, guiding patients and their families towards appropriate medical and support services.
The "Bone Marrow Failure Anemia Panel NGS (Next-Generation Sequencing) Genetic Test" is a comprehensive diagnostic tool offered by DNA Labs UAE, designed to detect genetic mutations associated with bone marrow failure syndromes. This advanced testing method utilizes next-generation sequencing technology to analyze a broad panel of genes known to be involved in bone marrow failure, helping to identify the genetic underpinnings of anemia and related conditions. With a cost of 4400 AED, this test provides invaluable insights for the accurate diagnosis and tailored treatment of patients suffering from bone marrow failure anemias, guiding healthcare professionals in making informed decisions regarding patient care.
The Dysmorphology Panel NGS (Next-Generation Sequencing) Genetic Test is a sophisticated diagnostic tool offered by DNA Labs UAE, designed to identify genetic mutations responsible for dysmorphic features and congenital anomalies. This comprehensive test utilizes cutting-edge NGS technology to analyze multiple genes simultaneously, making it highly efficient in pinpointing the genetic basis of various dysmorphological syndromes. With a test cost of 4400 AED, the panel aims to provide crucial insights into the genetic disorders affecting an individual's physical appearance and structural development, facilitating early diagnosis and personalized management plans. DNA Labs UAE ensures precision, reliability, and confidentiality in delivering results, empowering healthcare professionals and families with essential genetic information to guide clinical decisions and support.
The "Ciliopathies Panel NGS Genetic Test" offered by DNA Labs UAE is a comprehensive diagnostic tool designed to detect genetic mutations associated with ciliopathies, a group of rare, genetically heterogeneous disorders. These disorders are caused by dysfunction in cilia, the microscopic, hair-like structures on the surface of cells that play crucial roles in cell movement, signaling, and coordination. Ciliopathies can affect multiple organ systems, leading to a wide range of symptoms and conditions, including kidney disease, retinal degeneration, brain malformations, and more.
This panel utilizes Next-Generation Sequencing (NGS) technology, a cutting-edge approach that allows for the simultaneous sequencing of multiple genes. This is particularly useful for diseases like ciliopathies, where mutations in any of several different genes can result in similar clinical manifestations. The NGS method enhances the accuracy, efficiency, and comprehensiveness of genetic testing, enabling healthcare providers to make more informed decisions regarding diagnosis, treatment, and management of these complex conditions.
The cost of the Ciliopathies Panel NGS Genetic Test at DNA Labs UAE is 4400 AED. This investment covers the detailed analysis of a broad spectrum of genes associated with ciliopathies, offering patients and their families critical insights into their genetic health. By identifying specific genetic mutations, the test can help in confirming a diagnosis, understanding the risk of developing certain conditions, and in some cases, guiding targeted therapy and management strategies.
The Breast Comprehensive Panel NGS (Next-Generation Sequencing) Genetic Test is a cutting-edge diagnostic tool offered by DNA Labs UAE, designed to provide an in-depth analysis of genetic mutations associated with breast cancer. Priced at 4400 AED, this comprehensive test screens for a wide array of genetic markers that are known to influence the risk of developing breast cancer. Utilizing the latest NGS technology, the panel can simultaneously analyze multiple genes to detect mutations with high accuracy and speed, enabling personalized risk assessment and guiding targeted treatment options. This test is especially valuable for individuals with a family history of breast cancer or those seeking to understand their genetic predisposition to the disease. By providing detailed genetic insights, the Breast Comprehensive Panel NGS Genetic Test empowers patients and healthcare providers to make informed decisions regarding prevention, surveillance, and management strategies for breast cancer.
The Cancer Comprehensive Panel NGS (Next-Generation Sequencing) Genetic Test, available at DNA Labs UAE, is a cutting-edge diagnostic tool designed to provide a detailed analysis of an individual's genetic predisposition to various types of cancer. Priced at 4400 AED, this test utilizes the latest NGS technology to examine multiple genes simultaneously, allowing for the identification of mutations that could increase the risk of developing cancer.
By analyzing a wide array of genes associated with hereditary cancers, the test offers a comprehensive overview of the genetic factors that may contribute to cancer risk. This information is crucial for individuals with a family history of cancer, as it can guide personalized prevention strategies, early detection methods, and tailor treatment plans to improve outcomes.
The test is conducted at DNA Labs UAE, a facility renowned for its state-of-the-art technology and expertise in genetic testing. The process involves a simple blood draw or saliva sample from which DNA is extracted and analyzed. The results provide valuable insights into the patient's genetic makeup, empowering them with the knowledge to take proactive steps in managing their health in collaboration with healthcare professionals.
In summary, the Cancer Comprehensive Panel NGS Genetic Test at DNA Labs UAE is a vital tool in the fight against cancer, offering individuals a deeper understanding of their genetic risk factors and facilitating informed decisions regarding their health and well-being.
The "Colon Cancer Comprehensive Panel NGS (Next-Generation Sequencing) Genetic Test" is a sophisticated diagnostic tool offered by DNA Labs UAE, aimed at identifying genetic mutations associated with an increased risk of colon cancer. This test, priced at 4400 AED, leverages the cutting-edge NGS technology to meticulously analyze multiple genes simultaneously, providing a comprehensive overview of genetic variants that may contribute to the development of colon cancer.
By examining a broad panel of genes known to be linked with colon cancer, the test offers valuable insights that can guide personalized prevention strategies, inform treatment options, and help in the management of the disease. It is particularly beneficial for individuals with a family history of colon cancer or those who have been identified as at high risk based on other genetic tests or clinical factors.
Performed in the state-of-the-art facilities of DNA Labs UAE, this test requires a simple blood sample or a cheek swab from the patient. The results from the test can help healthcare providers make more informed decisions regarding surveillance, lifestyle modifications, and, if necessary, medical interventions to reduce the risk of colon cancer.
The comprehensive nature of the test, combined with the expertise of DNA Labs UAE, makes it a valuable resource for individuals seeking to understand their genetic risk for colon cancer and take proactive steps towards their health management.
